Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ingrid A Cox"'
Autor:
Alyson W Wong, Huiying Sun, Ingrid A Cox, Jolene H Fisher, Nasreen Khalil, Kerri A Johannson, Veronica Marcoux, Deborah Assayag, Helene Manganas, Martin Kolb, Andrew J Palmer, Barbara de Graaff, E Haydn Walters, Peter Hopkins, Christopher Zappala, Nicole S Goh, Yuben Moodley, Vidya Navaratnam, Tamera J Corte, Christopher J Ryerson, Wei Zhang
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283110 (2023)
ObjectivesFibrotic interstitial lung disease (ILD) includes a large group of conditions that lead to scarring of the lungs. The lack of available 5-level EuroQol 5D (EQ5D) data has limited the ability to conduct economic evaluations in ILD. The purpo
Externí odkaz:
https://doaj.org/article/15fdc94987af468a80bd1f82ad217002
Autor:
Ngan T. T. Dinh, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Brian Stokes, Andrew J. Palmer
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
AimsOur study aimed to identify the common themes, knowledge gaps and to evaluate the quality of data linkage research on diabetes in Australia.MethodsThis systematic review was developed in accordance with the Preferred Reporting Items for Systemati
Externí odkaz:
https://doaj.org/article/1c4ad4399a0e42b7946aca7deb57c6fc
Autor:
Qiang Zheng, Ingrid A. Cox, Julie A. Campbell, Qing Xia, Petr Otahal, Barbara de Graaff, Tamera J. Corte, Alan K.Y. Teoh, E. Haydn Walters, Andrew J. Palmer
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Background There are substantial advances in diagnosis and treatment for idiopathic pulmonary fibrosis (IPF), but without much evidence available on recent mortality and survival trends. Methods A narrative synthesis approach was used to investigate
Externí odkaz:
https://doaj.org/article/05fdea094fb34f30b35a159a27d1dc8b
Autor:
Qiang Zheng, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Tamera J. Corte, Ian Glaspole, Vidya Navaratnam, Peter Hopkins, Chris Zappala, Hasnat Ahmad, Ting Zhao, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer
Publikováno v:
Quality of Life Research. 32:1609-1619
Little is known about the impact of co-morbidities on health-related quality of life (HRQoL) for people with idiopathic pulmonary fibrosis (IPF). We aimed to investigate the relative contribution of co-morbidities to HRQoL of people with IPF.N = 157
Autor:
Ingrid A. Cox, Julie Campbell, Barbara de Graaff, Petr Otahal, Tamera J. Corte, Yuben Moodley, Peter Hopkins, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer
Publikováno v:
Quality of Life Research. 32:473-493
Purpose Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating chronic lung disease with a high symptom burden, which has a substantial impact on health-related quality of life (HRQoL). Our study aimed to assess the suitability of the
Autor:
Alyson W. Wong, Huiying Sun, Ingrid A. Cox, Jolene H. Fisher, Nasreen Khalil, Kerri A. Johannson, Veronica Marcoux, Deborah Assayag, Helene Manganas, Martin Kolb, Andrew J. Palmer, Barbara de Graaff, E. Haydn Walters, Peter Hopkins, Christopher Zappala, Nicole S. Goh, Yuben Moodley, Vidya Navaratnam, Tamera J. Corte, Christopher J. Ryerson, Wei Zhang
Publikováno v:
D102. HIGHLIGHTS OF EPIDEMIOLOGIC AND CLINICAL RESEARCH IN BEHAVIORAL SCIENCES.
Objectives Fibrotic interstitial lung disease (ILD) includes a large group of conditions that lead to scarring of the lungs. The lack of available 5-level EuroQol 5D (EQ5D) data has limited the ability to conduct economic evaluations in ILD. The purp
Autor:
Qiang Zheng, Petr Otahal, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Hasnat Ahmad, E. Haydn Walters, Andrew J. Palmer
Publikováno v:
Frontiers in Medicine. 10
BackgroundImmortal time bias (ITB) has been overlooked in idiopathic pulmonary fibrosis (IPF). We aimed to identify the presence of ITB in observational studies examining associations between antifibrotic therapy and survival in patients with IPF and
Autor:
E. Haydn Walters, Tamera J. Corte, Yuben Moodley, Ian Glaspole, Barbara de Graaff, Ingrid A. Cox, Andrew J. Palmer, Alan Teoh, Daniel C. Chambers
Publikováno v:
Australian Health Review. 45:718-727
Objectives Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease presenting in people aged ≥50 years. There is currently no cure for IPF, but two medications (pirfenidone and nintedanib) have been shown to
Autor:
E. Haydn Walters, Ian Glaspole, Nicole S L Goh, Hasnat Ahmed, Ingrid A. Cox, Sacha Macansh, Barbara de Graaff, Petr Otahal, Andrew J. Palmer, Julie A Campbell, Yuben Moodley, Tamera J. Corte
Publikováno v:
Quality of Life Research. 30:2615-2632
Idiopathic pulmonary fibrosis (IPF) is a progressive and universally fatal lung disease, characterised by increasing fibrosis of the lung parenchyma. In this study, we aimed to quantify the health state utility values (HSUVs) for Australians with IPF
Autor:
Ingrid A. Cox, Barbara de Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal, Tamera J. Corte, Yuben Moodley, Nicole Goh, Peter Hopkins, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care.
Purpose Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease found mostly in elderly persons, characterized by a high symptom burden and frequent encounters with health services. This study aimed to quantify the economic burden